Limits...
2-Methoxystypandrone inhibits signal transducer and activator of transcription 3 and nuclear factor-κB signaling by inhibiting Janus kinase 2 and IκB kinase.

Kuang S, Qi C, Liu J, Sun X, Zhang Q, Sima Z, Liu J, Li W, Yu Q - Cancer Sci. (2014)

Bottom Line: We have identified 2-methoxystypandrone (2-MS) from a traditional Chinese medicinal herb Polygonum cuspidatum as a novel dual inhibitor of JAK2 and IKK. 2-MS inhibits both interleukin-6-induced and constitutively-activated STAT3, as well as tumor necrosis factor-α-induced NF-κB activation. 2-MS specifically inhibits JAK and IKKβ kinase activities but has little effect on activities of other kinases tested.The inhibitory effects of 2-MS on STAT3 and NF-κB signaling can be eliminated by DTT or glutathione and can last for 4 h after a pulse treatment.We propose that the natural compound 2-MS, as a potent dual inhibitor of STAT3 and NF-κB pathways, is a promising anticancer drug candidate.

View Article: PubMed Central - PubMed

Affiliation: Division of Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.

Show MeSH

Related in: MedlinePlus

Effects of 2-methoxystypandrone (2-MS) on signal transducer and activator of transcription 3 (STAT3) and NF-κB signaling can be abolished by DTT or GSH treatment and were irreversible. (a) 20 μM 2-MS were incubated with or without 500 μM DTT or GSH at 37°C for 1 h before being added to HeLa cells for 2 h, followed by stimulation with interleukin-6 (IL-6) (30 ng/mL) for 15 min. Whole cell lysates were processed for western blot analysis and probed with anti-P-STAT3 (Y705) antibodies. Anti-STAT3 and anti-α-Tubulin antibodies were used as loading controls. (b) HeLa cells were pretreated with 20 μM 2-MS for 2 h and then washed with fresh medium for three times. After the indicated time periods, the cells were stimulated with IL-6 (30 ng/mL) for 15 min. Whole cell lysates were processed for western blot analysis. (c) 20 μM 2-MS were incubated with or without 500 μM DTT or GSH at 37°C for 1 h before being added to HeLa cells for 2 h, followed by stimulation with tumor necrosis factor-α (TNF-α) (2 ng/mL) for 15 min. Whole cell lysates were subjected to western blot analysis and probed with anti-P-IκB-α (Ser32/36) and anti-IκB-α antibodies. Anti-α-Tubulin antibodies were used as a loading control. (d) HeLa cells were pretreated with 20 μM 2-MS for 2 h and then washed with fresh medium three times. After the indicated time periods, the cells were stimulated with TNF-α (2 ng/mL) for 15 min. Whole cell lysates were processed for western blot analysis.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4317813&req=5

fig05: Effects of 2-methoxystypandrone (2-MS) on signal transducer and activator of transcription 3 (STAT3) and NF-κB signaling can be abolished by DTT or GSH treatment and were irreversible. (a) 20 μM 2-MS were incubated with or without 500 μM DTT or GSH at 37°C for 1 h before being added to HeLa cells for 2 h, followed by stimulation with interleukin-6 (IL-6) (30 ng/mL) for 15 min. Whole cell lysates were processed for western blot analysis and probed with anti-P-STAT3 (Y705) antibodies. Anti-STAT3 and anti-α-Tubulin antibodies were used as loading controls. (b) HeLa cells were pretreated with 20 μM 2-MS for 2 h and then washed with fresh medium for three times. After the indicated time periods, the cells were stimulated with IL-6 (30 ng/mL) for 15 min. Whole cell lysates were processed for western blot analysis. (c) 20 μM 2-MS were incubated with or without 500 μM DTT or GSH at 37°C for 1 h before being added to HeLa cells for 2 h, followed by stimulation with tumor necrosis factor-α (TNF-α) (2 ng/mL) for 15 min. Whole cell lysates were subjected to western blot analysis and probed with anti-P-IκB-α (Ser32/36) and anti-IκB-α antibodies. Anti-α-Tubulin antibodies were used as a loading control. (d) HeLa cells were pretreated with 20 μM 2-MS for 2 h and then washed with fresh medium three times. After the indicated time periods, the cells were stimulated with TNF-α (2 ng/mL) for 15 min. Whole cell lysates were processed for western blot analysis.

Mentions: As shown in Fig. 1, 2-MS contains three α,β-unsaturated carbonyl groups which are reactive with thiols. The thiols of cysteines in JAK2 and IKKβ are reported to be important for their kinase activities and several compounds with thiol-reactive groups have been found to covalently bind to Cysteine 179 of IKKβ and inhibit its kinase activity.(23–26) Therefore, we investigated whether the inhibitory effects of 2-MS on JAK2 or IKKβ kinase activity were through interacting with their cysteine thiols. We used two thiol-containing compounds, DTT or GSH, to compete with JAK2 or IKKβ on interacting with 2-MS to test whether the inhibitory effects of 2-MS on the STAT3 or NF-κB pathway could be alleviated by the two thiol-containing compounds. As shown in Figure. 5(a) and (c), after incubation with DTT or GSH, the inhibitory effects of 2-MS on STAT3 and NF-κB pathways were abolished. Therefore, 2-MS may inhibit the STAT3 and NF-κB pathways through interacting with the thiols of JAK2 and IKKβ via its α,β-unsaturated carbonyl groups. To further demonstrate the 2-MS-thiol interaction, 2-MS was mixed with DTT to induce a chemical reaction of Michael addiction. The proposed reaction site of 2-MS is illustrated in Fig. 6(a). The Michael adducts of DTT to 2-MS were then examined using TLC and ESI-MS analysis, which detected one product at m/z 412.97 [2-MS + DTT-H]−, indicating the addition of DTT to 2-MS (Fig. 6b,c). The results strongly support the possibility that 2-MS reacts with the cysteine thiols of JAK2 and IKKβ.


2-Methoxystypandrone inhibits signal transducer and activator of transcription 3 and nuclear factor-κB signaling by inhibiting Janus kinase 2 and IκB kinase.

Kuang S, Qi C, Liu J, Sun X, Zhang Q, Sima Z, Liu J, Li W, Yu Q - Cancer Sci. (2014)

Effects of 2-methoxystypandrone (2-MS) on signal transducer and activator of transcription 3 (STAT3) and NF-κB signaling can be abolished by DTT or GSH treatment and were irreversible. (a) 20 μM 2-MS were incubated with or without 500 μM DTT or GSH at 37°C for 1 h before being added to HeLa cells for 2 h, followed by stimulation with interleukin-6 (IL-6) (30 ng/mL) for 15 min. Whole cell lysates were processed for western blot analysis and probed with anti-P-STAT3 (Y705) antibodies. Anti-STAT3 and anti-α-Tubulin antibodies were used as loading controls. (b) HeLa cells were pretreated with 20 μM 2-MS for 2 h and then washed with fresh medium for three times. After the indicated time periods, the cells were stimulated with IL-6 (30 ng/mL) for 15 min. Whole cell lysates were processed for western blot analysis. (c) 20 μM 2-MS were incubated with or without 500 μM DTT or GSH at 37°C for 1 h before being added to HeLa cells for 2 h, followed by stimulation with tumor necrosis factor-α (TNF-α) (2 ng/mL) for 15 min. Whole cell lysates were subjected to western blot analysis and probed with anti-P-IκB-α (Ser32/36) and anti-IκB-α antibodies. Anti-α-Tubulin antibodies were used as a loading control. (d) HeLa cells were pretreated with 20 μM 2-MS for 2 h and then washed with fresh medium three times. After the indicated time periods, the cells were stimulated with TNF-α (2 ng/mL) for 15 min. Whole cell lysates were processed for western blot analysis.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4317813&req=5

fig05: Effects of 2-methoxystypandrone (2-MS) on signal transducer and activator of transcription 3 (STAT3) and NF-κB signaling can be abolished by DTT or GSH treatment and were irreversible. (a) 20 μM 2-MS were incubated with or without 500 μM DTT or GSH at 37°C for 1 h before being added to HeLa cells for 2 h, followed by stimulation with interleukin-6 (IL-6) (30 ng/mL) for 15 min. Whole cell lysates were processed for western blot analysis and probed with anti-P-STAT3 (Y705) antibodies. Anti-STAT3 and anti-α-Tubulin antibodies were used as loading controls. (b) HeLa cells were pretreated with 20 μM 2-MS for 2 h and then washed with fresh medium for three times. After the indicated time periods, the cells were stimulated with IL-6 (30 ng/mL) for 15 min. Whole cell lysates were processed for western blot analysis. (c) 20 μM 2-MS were incubated with or without 500 μM DTT or GSH at 37°C for 1 h before being added to HeLa cells for 2 h, followed by stimulation with tumor necrosis factor-α (TNF-α) (2 ng/mL) for 15 min. Whole cell lysates were subjected to western blot analysis and probed with anti-P-IκB-α (Ser32/36) and anti-IκB-α antibodies. Anti-α-Tubulin antibodies were used as a loading control. (d) HeLa cells were pretreated with 20 μM 2-MS for 2 h and then washed with fresh medium three times. After the indicated time periods, the cells were stimulated with TNF-α (2 ng/mL) for 15 min. Whole cell lysates were processed for western blot analysis.
Mentions: As shown in Fig. 1, 2-MS contains three α,β-unsaturated carbonyl groups which are reactive with thiols. The thiols of cysteines in JAK2 and IKKβ are reported to be important for their kinase activities and several compounds with thiol-reactive groups have been found to covalently bind to Cysteine 179 of IKKβ and inhibit its kinase activity.(23–26) Therefore, we investigated whether the inhibitory effects of 2-MS on JAK2 or IKKβ kinase activity were through interacting with their cysteine thiols. We used two thiol-containing compounds, DTT or GSH, to compete with JAK2 or IKKβ on interacting with 2-MS to test whether the inhibitory effects of 2-MS on the STAT3 or NF-κB pathway could be alleviated by the two thiol-containing compounds. As shown in Figure. 5(a) and (c), after incubation with DTT or GSH, the inhibitory effects of 2-MS on STAT3 and NF-κB pathways were abolished. Therefore, 2-MS may inhibit the STAT3 and NF-κB pathways through interacting with the thiols of JAK2 and IKKβ via its α,β-unsaturated carbonyl groups. To further demonstrate the 2-MS-thiol interaction, 2-MS was mixed with DTT to induce a chemical reaction of Michael addiction. The proposed reaction site of 2-MS is illustrated in Fig. 6(a). The Michael adducts of DTT to 2-MS were then examined using TLC and ESI-MS analysis, which detected one product at m/z 412.97 [2-MS + DTT-H]−, indicating the addition of DTT to 2-MS (Fig. 6b,c). The results strongly support the possibility that 2-MS reacts with the cysteine thiols of JAK2 and IKKβ.

Bottom Line: We have identified 2-methoxystypandrone (2-MS) from a traditional Chinese medicinal herb Polygonum cuspidatum as a novel dual inhibitor of JAK2 and IKK. 2-MS inhibits both interleukin-6-induced and constitutively-activated STAT3, as well as tumor necrosis factor-α-induced NF-κB activation. 2-MS specifically inhibits JAK and IKKβ kinase activities but has little effect on activities of other kinases tested.The inhibitory effects of 2-MS on STAT3 and NF-κB signaling can be eliminated by DTT or glutathione and can last for 4 h after a pulse treatment.We propose that the natural compound 2-MS, as a potent dual inhibitor of STAT3 and NF-κB pathways, is a promising anticancer drug candidate.

View Article: PubMed Central - PubMed

Affiliation: Division of Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.

Show MeSH
Related in: MedlinePlus